Myriad Genetics, Inc (NASDAQ: MYGN) Not A Good Play Anymore?
Myriad Genetics, Inc (MYGN) concluded trading on Thursday at a closing price of $5.6, with 0.46 million shares of worth about $2.6 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -58.91% during that period and on July 03, 2025 the price saw a […]